Amphastar P (AMPH)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 137,545 | 91,386 | 62,116 | 1,403 | 48,939 |
| Total assets | US$ in thousands | 1,512,910 | 741,987 | 671,529 | 631,236 | 586,971 |
| ROA | 9.09% | 12.32% | 9.25% | 0.22% | 8.34% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $137,545K ÷ $1,512,910K
= 9.09%
Amphastar Pharmaceuticals Inc's return on assets (ROA) has fluctuated over the past five years. In 2023, ROA stood at 9.09%, showing a decrease from the previous year's figure of 12.32%. Despite this decline, the ROA in 2023 remains above the levels seen in 2020 and 2019. The highest ROA in the provided period was observed in 2022 at 12.32%, indicating strong asset utilization and profitability during that year. In contrast, the ROA was significantly lower in 2020 at 0.22%, indicating potential issues with asset management and profitability that year. Overall, Amphastar Pharmaceuticals Inc's ROA has shown variability, reflecting changes in the company's ability to generate profits from its assets over the years.
Peer comparison
Dec 31, 2023